Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Cancer Investigation|November 25, 2003
Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinomaFlorian Eckel, Renate Schmelz, Johannes Erdmann, et al.
Clinical Colorectal Cancer|November 28, 2002
Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancerChristian Lersch, Renate Schmelz, Florian Eckel, et al.
Deutsche Medizinische Wochenschrift (1946)|February 4, 2016
[Infections in inflammatory bowel disease]Sebastian Zeissig, Renate Schmelz
Investigational New Drugs|September 20, 2006
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II studyStefan von Delius, Florian Eckel, Stefan Wagenpfeil, et al.
Deutsche Medizinische Wochenschrift (1946)|October 5, 2018
[Practical Genetic Testing in Gastroenterology]Margarete Hohmann, Renate Schmelz, Jochen Hampe, et al.
Nutrients|September 9, 2022
Chemosensory Functions in Patients with Inflammatory Bowel Disease and Their Association with Clinical Disease ActivityXingyu Han, Ayda-Ayleen Ordouie, Renate Schmelz, et al.
Crohn'S & Colitis 360|February 13, 2023
Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data AnalysisJoerg Mahlich, Melanie May, Chiara Feig, et al.
World Journal of Gastroenterology|July 31, 2007
Therapy of gastric mucosa associated lymphoid tissue lymphomaAndrea Morgner, Renate Schmelz, Christian Thiede, et al.
Scientific Reports|October 26, 2017
Specific neurophysiological mechanisms underlie cognitive inflexibility in inflammatory bowel diseaseVanessa A Petruo, Sebastian Zeißig, Renate Schmelz, et al.
Cancer Investigation|March 21, 2002
Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot studyFlorian Eckel, Christian Lersch, Gerald Assmann, et al.
Pageof 5